Impact of HIV status on prognosis of malignancies among people living with HIV in Japan
Cancer · 2024
DOI: 10.1002/cncr.35351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Kenju Ando und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: HIV Infections, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Background
Antiretroviral therapy has reduced the incidence and mortality of AIDS‐defining malignancies (ADM); however, non–AIDS‐defining malignancies (NADM) are a major cause of death among people living with HIV (PLWH) today. Though current guidelines suggest that PLWH should receive the same treatment as the general population, there are limited studies focused on how HIV status affects the prognosis of cancers. The present study aimed to investigate the characteristics and prognosis of malignant diseases among PLWH in Japan.
Methods
Patients with HIV diagnosed with malignant diseases at our institution between 2011 and 2021 were retrospectively reviewed.
Results
There were 205 patients who were diagnosed with malignancies. Of these, 87 (42.4%) were diagnosed with ADM and 118 (57.6%) were diagnosed with NADM. Among 69 patients who received chemotherapy for ADM, 24 (34.8%) developed AIDS‐defining opportunistic infections during treatment. In contrast, only one (1.8%) of the 56 patients administered chemotherapy for NADM developed AIDS‐defining opportunistic infections. Complications of opportunistic infections at diagnosis of malignancies, low CD4 + T‐cell count, positive HIV RNA, and nonadministration of antiretroviral therapy were associated with 5‐year overall survival among patients with malignant lymphomas. However, the variables associated with HIV did not affect NADM prognosis.
Conclusions
In this analysis, HIV status had a small impact on the prognosis of malignant diseases in PLWH. Few patients with NADM developed AIDS‐defining opportunistic infections after receiving chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
- Course of Advanced and Specialized Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
- AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
- Division of Host Defense Mechanism, Tokai University School of Medicine, Kanagawa, Japan.
- National Hospital Organization Higashisaitama Hospital, Saitama, Japan.
ORCID-Profile: Kenju Ando, Akihiko Shimomura
Förderung
- Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
Zitieren
APA
Ando, K., Shimomura, A., Watanabe, K., Tsukada, K., Teruya, K., Gatanaga, H., & Shimizu, C. (2024). Impact of HIV status on prognosis of malignancies among people living with HIV in Japan. Cancer. https://doi.org/10.1002/cncr.35351
Vancouver
Ando K, Shimomura A, Watanabe K, Tsukada K, Teruya K, Gatanaga H, et al. Impact of HIV status on prognosis of malignancies among people living with HIV in Japan. Cancer. 2024. doi:10.1002/cncr.35351
BibTeX
@article{Ando2024,
author = {Ando, Kenju and Shimomura, Akihiko and Watanabe, Koji and Tsukada, Kunihisa and Teruya, Katsuji and Gatanaga, Hiroyuki and Shimizu, Chikako},
title = {Impact of HIV status on prognosis of malignancies among people living with HIV in Japan},
journal = {Cancer},
year = {2024},
doi = {10.1002/cncr.35351}
}
EUVIMED